The pathbreaking drug that could cure cancer in few weeks time
A team of scientists from Israel claim to have developed a drug that could potentially cure cancer in few weeks time. That too with minimal side effects.
The Jerusalem Post reports that a team of researchers from Accelerated Evolution Biotechnologies Ltd (AEBi) claims to have found the first complete cure for cancer.
THE COMPANY WILL SOON BEGIN THE FIRST ROUND OF CLINICAL TRIALS WHICH COULD BE COMPLETED WITHIN A FEW YEARS
The treatment, called MuTaTo (multi-target toxin) uses a combination of cancer-targeting peptides and a toxin that specifically kills cancer cells. The drug cocktail, akin to a cancer antibiotic would be specific to each patient based on his/her biopsy sample and would kill only cancer cells without causing any harm to normal cells.
And, because only the cancer cells would be killed, patients could likely stop treatment after a number of weeks, reports the Post.
According to World Health Organization, Cancer is the second leading cause of death globally. It is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer and approximately 70% of deaths from cancer occur in low- and middle-income countries.
“We believe we will offer in a year’s time a complete cure for cancer,” said Dan Aridor, chairman of the board of AEBi while talking to the paper. “Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market,” commented Aridor to the Post.
Dr. Ilan Morad, CEO of the company told the Post that their first experiment in mice showed promising results. It inhibited human cancer cell growth and had no effect at all on healthy mice cells, in addition to several in-vitro trials.
The company will soon begin the first round of clinical trials which could be completed within a few years and would make the treatment available in specific cases, the Post reported.
